BCMA-CD19 CAR-T therapy: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 2 1

Condition	Trials
ANCA-associated Vasculitis	1
Acquired Thrombotic Thrombocytopenic Purpura	1
Antiphospholipid Syndrome	1
Behcet Disease	1
IgG4-Related Diseases	1
Inflammatory Myopathy	1
Lupus	1
Multiple sclerosis	1
Rheumatoid arthritis	1
Sjogren Syndrome	1
Systemic Lupus Erythematosus	1
Systemic Sclerosis (SSc)	1

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
NCT06794008 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations

1 recruiting trial across 12 conditions.

No. For the full record, search ClinicalTrials.gov.